ASH 2020: Hematologic Malignancy Represents a Vulnerable Risk Group for Poor COVID-19 Outcomes
These patients should take precautions to avoid contracting COVID-19 and be prioritized for the vaccine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.